RhumbLine Advisers’s Livongo Health, Inc. Common Stock LVGO Stock Holding History

RhumbLine Advisers’s Portfolio LVGO Stock Details LVGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-61,730	Closed	-$8.64M	–	3065
2020 Q3	$8.64M	Sell	61,730 -1,867	-3%	-$227K	0.01%	849
2020 Q2	$4.78M	Sell	63,597 -5,568	-8%	-$291K	0.01%	1243
2020 Q1	$1.97M	Buy	69,165 +52,733	+321%	+$1.37M	﹤0.01%	1552
2019 Q4	$412K	Buy	16,432 +2,793	+20%	+$66.8K	﹤0.01%	2450
2019 Q3	$238K	Buy	+13,639	New	+$412K	﹤0.01%	2685

RhumbLine Advisers's LVGO Position: Q4 2020 in Review

RhumbLine Advisers sold out of Livongo Health, Inc. Common Stock (LVGO) in Q4 2020, closing a stake of 61,730 shares — an estimated $8.64M sold.

RhumbLine Advisers first reported a position in LVGO in Q3 2019 and held it in 5 quarters. The position peaked at $8.64M in Q3 2020. 0 funds tracked by Wall St. Rank hold LVGO as of Q4 2020.

RhumbLine Advisers reported no remaining Livongo Health, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
RhumbLine Advisers sold 61,730 Livongo Health, Inc. Common Stock shares in Q4 2020, an estimated $8.64M.
RhumbLine Advisers first reported a position in Livongo Health, Inc. Common Stock in Q3 2019 and held it in 5 quarters.
RhumbLine Advisers's Livongo Health, Inc. Common Stock position peaked at $8.64M in Q3 2020.
0 funds tracked by Wall St. Rank held Livongo Health, Inc. Common Stock as of Q4 2020.

Based on RhumbLine Advisers's 13F filing for Q4 2020, filed 10 Feb 2021.